Root Financial Partners’s Bicara Therapeutics BCAX Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAX
SL
Root Financial Partners's BCAX Position: Q3 2026 in Review
Root Financial Partners opened a new position in Bicara Therapeutics (BCAX) in Q3 2026: 38 shares worth $707. The stake represents ﹤0.01% of the portfolio and ranks #3098 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in BCAX as recently as Q1 2026.
Root Financial Partners first reported a position in BCAX in Q1 2026 and has held it in 2 quarters since. 169 funds tracked by Wall St. Rank hold BCAX as of Q3 2026.
- Root Financial Partners held 38 shares of Bicara Therapeutics worth $707 as of Q3 2026.
- Bicara Therapeutics was a new Root Financial Partners position in Q3 2026.
- Bicara Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3098 holding.
- Root Financial Partners first reported a position in Bicara Therapeutics in Q1 2026 and has held it in 2 quarters since.
- 169 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q3 2026.
Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.